Chemoradiotherapy vs radiotherapy for nonoperative early stage esophageal cancer: A seer data analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemoradiotherapy vs radiotherapy for nonoperative early stage esophageal cancer: A seer data analysis

Published:2020-05-22 Issue:14 Volume:9 Page:5025-5034
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Li Jiaxin¹,Jia Yibin¹,Cheng Yufeng¹^ORCID,Wang Jianbo¹

Affiliation:

1. Department of Radiation Oncology Qilu HospitalCheeloo College of MedicineShandong University Jinan Shandong China

Funder

Taishan Scholar Project of Shandong Province

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3132

Reference22 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Global cancer statistics, 2012

3. Global incidence of oesophageal cancer by histological subtype in 2012

4. Epidemiology of esophageal cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomograms for prognosis prediction in esophageal adenocarcinoma: realities and challenges;Clinical and Translational Oncology;2024-07-31

2. Nuclear factor erythroid 2-related factor 2 promotes radioresistance by regulating glutamate-cysteine ligase modifier subunit and its unique immunoinvasive pattern;Biomolecules and Biomedicine;2024-05-02

3. Definitive radiotherapy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: A multicenter retrospective study (KROG 21–10);Radiotherapy and Oncology;2023-12

4. Development and validation of a nomogram to predict cardiac death after radiotherapy for esophageal cancer;Cancer Innovation;2023-09

5. Real-world experience with anti–programmed cell death protein 1 immunotherapy in patients with esophageal cancer: A retrospective single-center study;Frontiers in Oncology;2022-09-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3